SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Galirayo who wrote (980)6/7/2005 2:04:52 PM
From: tuck  Read Replies (1) | Respond to of 3722
 
Ray,

Looks like Chiron and Aventis are frontrunners:

www2.niaid.nih.gov

Vical may have a dark horse interest:

cdc.gov

Cheers, Tuck



To: Galirayo who wrote (980)6/7/2005 11:19:11 PM
From: John Metcalf  Read Replies (3) | Respond to of 3722
 
There's a long-running thread on SARS and bird flu. Henry Niman has posted frequently, and could probably tell you where programs are running.

Subject 53838

Some Asian programs have developed vaccines, which might be developed and tested and approved in the West. Despite its influenza debacle, Chiron might be a company to do it. Henry could advise.

Hey, hey, Viropharma! (No Avian flu program that I know of-:)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News